GENNEX LABORATORIES
Back to Income Statement
|
GENNEX LABORATORIES Last 5 Year Consolidated Net Profit History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Consolidated Net Profit | ₹18 Cr | ₹11 Cr | ₹6.19 Cr | ₹4.11 Cr | ₹4.04 Cr |
What is the latest Consolidated Net Profit of GENNEX LABORATORIES ?
| Year | Consolidated Net Profit |
|---|---|
| Mar2026 | ₹18 Cr |
| Mar2025 | ₹11 Cr |
| Mar2024 | ₹6.19 Cr |
| Mar2023 | ₹4.11 Cr |
| Mar2022 | ₹4.04 Cr |
How is Consolidated Net Profit of GENNEX LABORATORIES Trending?
| Years | Consolidated Net Profit | % Change | |
|---|---|---|---|
| Mar2026 | ₹18 Cr | 59.35 | |
| Mar2025 | ₹11 Cr | 83.61 | |
| Mar2024 | ₹6.19 Cr | 50.89 | |
| Mar2023 | ₹4.11 Cr | 1.66 | |
| Mar2022 | ₹4.04 Cr | - | |
Compare Consolidated Net Profit of peers of GENNEX LABORATORIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| GENNEX LABORATORIES | ₹212.5 Cr | -3.9% | -10.7% | -51.8% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹425,150.0 Cr | 0.8% | -2.1% | 4.8% | Stock Analytics | |
| DIVIS LABORATORIES | ₹266,265.0 Cr | 4.9% | 7.9% | 54.7% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹176,300.0 Cr | 1.6% | -2.7% | 28.1% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹114,351.0 Cr | 2.6% | 14.2% | 3.9% | Stock Analytics | |
| CIPLA | ₹112,474.0 Cr | 2.4% | 3.4% | -12% | Stock Analytics | |
GENNEX LABORATORIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| GENNEX LABORATORIES | -3.9% |
-10.7% |
-51.8% |
| SENSEX | 4.5% |
6.1% |
-9.3% |
You may also like the below Video Courses